Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials?

Ryan J, Cohen DJ, Pinto DS.

Coron Artery Dis. 2006 Dec;17(8):667-71. Review. Erratum in: Coron Artery Dis. 2007 Mar;18(2):149.

PMID:
17119374
2.

Drug-eluting coronary stents: many meta-analyses, little benefit.

[No authors listed]

Prescrire Int. 2009 Apr;18(100):70-4.

PMID:
19585727
3.

Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).

Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Kuck KH; DES.DE Study Group.

Am J Cardiol. 2009 Nov 15;104(10):1362-9. doi: 10.1016/j.amjcard.2009.06.058. Epub 2009 Sep 26.

PMID:
19892051
4.

5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.

Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R.

J Am Coll Cardiol. 2009 Sep 1;54(10):894-902. doi: 10.1016/j.jacc.2009.04.077.

5.

Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.

Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Seyfarth M, Varenne O, Dirksen MT, Percoco G, Varricchio A, Pittl U, Syvänne M, Suttorp MJ, Violini R, Schömig A.

Eur Heart J. 2007 Nov;28(22):2706-13. Epub 2007 Sep 27. Review.

PMID:
17901079
6.

Safety of drug-eluting stents in the coronary artery in ST-elevation myocardial infarction at a single high-volume medical center.

Bose R, Gupta G, Grayburn PA, Laible EA, Kang MJ, Choi JW.

Am J Cardiol. 2007 Sep 15;100(6):949-52. Epub 2007 Jul 2.

PMID:
17826375
7.
8.

Drug-eluting stents.

García-García HM, Vaina S, Tsuchida K, Serruys PW.

Arch Cardiol Mex. 2006 Jul-Sep;76(3):297-319. Review.

PMID:
17091802
9.

Drug-eluting versus bare metal stenting in acute myocardial infarction. A clinical review.

Jones WS, Washam JB, Meine TJ, Patel MR.

Minerva Cardioangiol. 2009 Oct;57(5):585-95. Review. Erratum in: Minerva Cardioangiol. 2009 Dec;57(6):830. Schuyler Jones, W [corrected to Jones, W S].

PMID:
19838149
10.

Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry.

Daemen J, Kukreja N, van Twisk PH, Onuma Y, de Jaegere PP, van Domburg R, Serruys PW.

Am J Cardiol. 2008 Apr 15;101(8):1105-11. doi: 10.1016/j.amjcard.2007.11.074. Epub 2008 Feb 20.

PMID:
18394442
11.

Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study).

Maresta A, Varani E, Balducelli M, Varbella F, Lettieri C, Uguccioni L, Sangiorgio P, Zoccai GB; DESSERT Investigators.

Am J Cardiol. 2008 Jun 1;101(11):1560-6. doi: 10.1016/j.amjcard.2008.01.040. Epub 2008 Apr 11.

PMID:
18489933
12.

Drug-eluting or bare-metal stents for acute myocardial infarction.

Mauri L, Silbaugh TS, Garg P, Wolf RE, Zelevinsky K, Lovett A, Varma MR, Zhou Z, Normand SL.

N Engl J Med. 2008 Sep 25;359(13):1330-42. doi: 10.1056/NEJMoa0801485.

13.

Paclitaxel-eluting stents in coronary artery disease.

Nawarskas JJ, Osborn LA.

Am J Health Syst Pharm. 2005 Nov 1;62(21):2241-51. Review.

PMID:
16239414
14.

The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials.

Kumbhani DJ, Bavry AA, Kamdar AR, Helton TJ, Bhatt DL.

Am Heart J. 2008 Apr;155(4):640-7. doi: 10.1016/j.ahj.2007.11.017. Epub 2008 Feb 21. Review.

PMID:
18371470
15.
16.

Drug eluting stents for ST-elevation myocardial infarction: risk and benefit.

Ryan J, Cutlip DE, Cohen DJ, Pinto DS.

J Thromb Thrombolysis. 2007 Dec;24(3):293-9. Epub 2007 May 5. Review.

PMID:
17483875
17.

Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials.

Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL.

Am J Med. 2006 Dec;119(12):1056-61.

PMID:
17145250
18.

Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation.

Stone GW, Ellis SG, Colombo A, Dawkins KD, Grube E, Cutlip DE, Friedman M, Baim DS, Koglin J.

Circulation. 2007 Jun 5;115(22):2842-7. Epub 2007 May 21.

19.

Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry).

Yan BP, Duffy SJ, Clark DJ, Lefkovits J, Warren R, Gurvitch R, Lew R, Sebastian M, Brennan A, Andrianopoulos N, Reid CM, Ajani AE; Melbourne Interventional Group.

Am J Cardiol. 2008 Jun 15;101(12):1716-22. doi: 10.1016/j.amjcard.2008.02.058. Epub 2008 Apr 9.

PMID:
18549846
20.

Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials.

Iijima R, Byrne RA, Dibra A, Ndrepepa G, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Suttorp MJ, Violini R, Schömig A, Kastrati A.

Rev Esp Cardiol. 2009 Apr;62(4):354-64. Review. English, Spanish.

Supplemental Content

Support Center